By Julia Symmes Cobb and Luis Jaime Acosta BOGOTA (Reuters) - Colombia will set a new price for the Novartis cancer drug imatinib in a bid to cut... ...https://in.news.yahoo.com/colombia-set-price-novartis-cancer-drug-minister-223736337--finance.html
Comments June 4, 2016 - London Novartis International AG /Novartis data show more than 50 percent of eligible Ph+ CML patients maintain... ...http://andhranews.net/Business/2016/Novartis-data-show-50-percent-eligible-22526.htm
"Real, meaningful progress remains elusive, and recent signals indicate backsliding in key areas. For instance, India just released its... ...http://www.businesstoday.in/current/policy/us-industry-sends-list-of-complaints-to-obama-ahead-of-modi%E2%80%99s-visit/story/233364.html
The Centre has formally recanted the gazette notification of May 18 by the Agriculture Ministry to cap the license fee for all new genetically... ...http://www.kashmirtimes.com/newsdet.aspx?q=53466
Novartis India, which sells the oncology drug Glivec, said on Thursday it will buy back shares worth Rs 290 crore. In a stock exchange filing, the... ...http://www.financialexpress.com/article/industry/companies/novartis-india-to-buy-back-shares-worth-rs-290-crore/266927/
Imatinib mesylate 400mg tablets is a...